Paradoxical aortic stiffening and subsequent cardiac dysfunction in Hutchinson–Gilford progeria syndrome

Sae‐Il Murtada, Yuki I. Kawamura, Alexander W. Caulk, H. Ahmadzadeh, Nicole Mikush, Kristin M. Zimmerman Savill, Dillon Kavanagh, Dar Weiss, Marcos Latorre, Zhen W. Zhuang, Gerald S. Shadel, Demetrios T. Braddock, Jay D. Humphrey

This study provides a deep dive into the biomechanical collapse of the aorta in a mouse model of Hutchinson-Gilford Progeria Syndrome (HGPS). By combining longitudinal physiological data with advanced computational modeling, the researchers reveal a "mechanical paradox": while the progeroid aorta becomes structurally stiffer—leading to heart failure—the actual material it is made of is abnormally soft. This dramatic decline occurs primarily in the final quarter of the animal's life, suggesting a potential therapeutic window for intervention in early adulthood.

TL;DR

Researchers discovered that in progeria, the aorta undergoes a "paradoxical" stiffening where the vessel wall thickens and loses function despite having low intrinsic material stiffness. This structural stiffening, driven by massive proteoglycan accumulation and smooth muscle cell loss, triggers late-stage diastolic heart failure but leaves a potential therapeutic window open during early maturity.

What Problem Does This Paper Address?

Hutchinson-Gilford Progeria Syndrome (HGPS) is a rare genetic "premature aging" disease caused by a mutation in the LMNA gene, leading to the production of a toxic protein called progerin. Children with HGPS typically die in their early teens from heart failure or stroke.

While clinicians knew that arterial stiffening was a hallmark of the disease, the exact mechanical progression was a "black box." We didn't know if the stiffness was due to the material itself getting harder (like old rubber) or the structure changing (like a thicker pipe). Furthermore, it was unclear how these vascular changes directly impacted cardiac function over time. This paper seeks to bridge the gap between the genetic mutation and the mechanical failure of the cardiovascular system.

Methods

The authors utilized a multi-scale approach to study a progeria mouse model ($Lmna^{G609G/G609G}$):

  1. In Vivo Physiology: They used high-frequency ultrasound (echocardiography) and micro-CT to track heart function and arterial dimensions in living mice.
  2. Biaxial Biomechanical Testing: Unlike standard tests that just pull on a tissue, they performed ex vivo biaxial testing—simultaneously inflating and stretching aortic segments to mimic physiological conditions.
  3. Allometric Scaling: Because progeria mice are significantly smaller than healthy mice, the team used allometric scaling (adjusting metrics based on body mass) to distinguish between "pathological" changes and changes simply due to smaller size.
  4. Particle-Based Computational Modeling: They developed a novel "particle-based" model of the aortic wall. This allowed them to simulate the specific contributions of individual components—like elastin, collagen, and proteoglycans—to see which factors were truly driving the stiffening.

Datasets

The study relied on primary data collected from:

  • Progeria Mice: $Lmna^{G609G/G609G}$ (studied at 100 and 140 days).
  • Control Mice: Wild-type littermates ($Lmna^{+/+}$).
  • Comparative Models: The authors compared their results against existing datasets for naturally aged mice (up to 700 days old), Marfan syndrome models ($Fbn1^{mgR/mgR}$), and induced hypertension models.

Key Insights and Ideas

  • The Structural Paradox: The progeroid aorta is structurally "stiff" (it takes more pressure to distend it), which increases Pulse Wave Velocity (PWV) and stresses the heart. However, the intrinsic material stiffness is actually lower than normal. The stiffness is a result of the wall getting much thicker and more disorganized, not the material getting "stronger."
  • The "Proteoglycan Pump": In late-stage progeria, the aorta accumulates massive amounts of glycosaminoglycans (GAGs). These molecules attract water (Gibbs-Donnan swelling), which physically pushes the elastic layers of the aorta apart and straightens them out, preventing them from storing energy during the heart's contraction.
  • Systolic vs. Diastolic: Surprisingly, the heart's pumping ability (systolic function) remains normal almost until death. The failure is "diastolic"—the heart becomes unable to fill properly because the stiff arteries reflect pressure waves back too quickly.
  • A Late-Life Decline: Vascular function is remarkably normal during development. The "crash" happens in the last 25% of the mouse's lifespan. This suggests that the damage is a cumulative response to mechanical stress over time, rather than an inherent developmental defect.

Key Results

  • Pulse Wave Velocity (PWV): PWV was dramatically higher in late-stage progeria (~6.16 m/s) compared to controls (~3.68 m/s), a classic sign of arterial stiffening.
  • Energy Storage Loss: The ability of the ascending aorta to store elastic energy (essential for maintaining blood flow between heartbeats) plummeted from ~88.5 kPa in controls to just 8.5 kPa in 140-day progeria mice.
  • Severity: 140-day-old progeria mice showed a more severe vascular phenotype than 700-day-old (extremely old) normal mice.
  • Smooth Muscle Loss: There was a total loss of vasoconstrictive capacity in the late stage, meaning the arteries could no longer actively regulate blood pressure.

Limitations and Future Work

  • Atherosclerosis Gap: While this mouse model captures the arterial stiffening of HGPS, it does not develop the accelerated atherosclerosis (plaque buildup) often seen in human patients.
  • Therapeutic Testing: The paper identifies a "therapeutic window" in early maturity but does not test specific drug interventions within that specific timeframe.
  • Molecular Trigger: While the mechanical role of GAGs is clear, the exact molecular signal that tells the cells to start overproducing them in response to progerin remains a subject for future research.

The study concludes that protecting smooth muscle cell phenotype and preventing proteoglycan accumulation in early adulthood could be the key to extending the lives of those with progeria.

Summary updated

Abstract

Hutchinson-Gilford progeria syndrome (HGPS) is an ultra-rare disorder with devastating sequelae resulting in early death, presently thought to stem primarily from cardiovascular events. We analyse novel longitudinal cardiovascular data from a mouse model of HGPS (<i>Lmna<sup>G609G/G609G</sup></i>) using allometric scaling, biomechanical phenotyping, and advanced computational modelling and show that late-stage diastolic dysfunction, with preserved systolic function, emerges with an increase in the pulse wave velocity and an associated loss of aortic function, independent of sex. Specifically, there is a dramatic late-stage loss of smooth muscle function and cells and an excessive accumulation of proteoglycans along the aorta, which result in a loss of biomechanical function (contractility and elastic energy storage) and a marked structural stiffening despite a distinctly low intrinsic material stiffness that is consistent with the lack of functional lamin A. Importantly, the vascular function appears to arise normally from the low-stress environment of development, only to succumb progressively to pressure-related effects of the lamin A mutation and become extreme in the peri-morbid period. Because the dramatic life-threatening aortic phenotype manifests during the last third of life there may be a therapeutic window in maturity that could alleviate concerns with therapies administered during early periods of arterial development.
BibTeX
@article{murtada2020paradoxical,
  author = {Sae‐Il Murtada and Yuki I. Kawamura and Alexander W. Caulk and H. Ahmadzadeh and Nicole Mikush and Kristin M. Zimmerman Savill and Dillon Kavanagh and Dar Weiss and Marcos Latorre and Zhen W. Zhuang and Gerald S. Shadel and Demetrios T. Braddock and Jay D. Humphrey},
  title = {{Paradoxical aortic stiffening and subsequent cardiac dysfunction in Hutchinson–Gilford progeria syndrome}},
  journal = {Journal of The Royal Society Interface},
  year = {2020},
  doi = {10.1098/rsif.2020.0066},
}
Figure